Literature DB >> 12616207

Distribution of respiratory mucin proteins in human nasal mucosa.

David A Groneberg1, Christian Peiser, Q Thai Dinh, John Matthias, Paul R Eynott, Werner Heppt, Ingemar Carlstedt, Christian Witt, Axel Fischer, K Fan Chung.   

Abstract

OBJECTIVES/HYPOTHESIS: The upper respiratory tract is involved in many acute and chronic respiratory tract diseases that present with the symptom of mucus hypersecretion. Mucin genes that encode for the backbone of glycoproteins contribute to the viscoelastic property of airway mucus. We examined the cellular expression and distribution of two major respiratory mucus-forming glycoproteins, MUC5AC and MUC5B, in normal human nasal tissues.
METHODS: Immunohistochemical analysis using polyclonal antibodies against the mucins MUC5AC and MUC5B was performed in normal human nasal tissues.
RESULTS: An abundant staining of submucosal mucus gland and epithelial goblet cells for MUC5B was found. Immunohistochemical analysis of MUC5AC showed staining of surface epithelium goblet cells, whereas there was no staining of glandular cells. Comparison of the expression to lower airways revealed a similar pattern of expression of both mucins.
CONCLUSIONS: The data in the present study demonstrated the localization of the two major respiratory mucin proteins in human nasal mucosa with a similar distribution of expression of MUC5AC and MUC5B in normal upper and lower airways. Mucin protein expression parallels that of mucin messenger RNA expression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12616207     DOI: 10.1097/00005537-200303000-00023

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  29 in total

1.  Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus.

Authors:  Samuel K Lai; D Elizabeth O'Hanlon; Suzanne Harrold; Stan T Man; Ying-Ying Wang; Richard Cone; Justin Hanes
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-23       Impact factor: 11.205

2.  Distribution of mucins and antimicrobial substances lysozyme and lactoferrin in the laryngeal subglottic region.

Authors:  Hannes Kutta; Andreas Willer; Philipp Steven; Lars Bräuer; Michael Tsokos; Friedrich Paulsen
Journal:  J Anat       Date:  2008-07-22       Impact factor: 2.610

Review 3.  Physicochemical properties of mucus and their impact on transmucosal drug delivery.

Authors:  Jasmim Leal; Hugh D C Smyth; Debadyuti Ghosh
Journal:  Int J Pharm       Date:  2017-09-14       Impact factor: 5.875

4.  Tobacco smoke particles and indoor air quality (ToPIQ) - the protocol of a new study.

Authors:  Daniel Mueller; Stefanie Uibel; Markus Braun; Doris Klingelhoefer; Masaya Takemura; David A Groneberg
Journal:  J Occup Med Toxicol       Date:  2011-12-21       Impact factor: 2.646

5.  cAMP-activated Ca2+ signaling is required for CFTR-mediated serous cell fluid secretion in porcine and human airways.

Authors:  Robert J Lee; J Kevin Foskett
Journal:  J Clin Invest       Date:  2010-08-25       Impact factor: 14.808

Review 6.  Chronic rhinosinusitis pathogenesis.

Authors:  Whitney W Stevens; Robert J Lee; Robert P Schleimer; Noam A Cohen
Journal:  J Allergy Clin Immunol       Date:  2015-12       Impact factor: 10.793

Review 7.  New insights into upper airway innate immunity.

Authors:  Benjamin M Hariri; Noam A Cohen
Journal:  Am J Rhinol Allergy       Date:  2016-09       Impact factor: 2.467

8.  Human barrier models for the in vitro assessment of drug delivery.

Authors:  Matthias Schweinlin; Angela Rossi; Nina Lodes; Christian Lotz; Stephan Hackenberg; Maria Steinke; Heike Walles; Florian Groeber
Journal:  Drug Deliv Transl Res       Date:  2017-04       Impact factor: 4.617

9.  Long-term ozone exposure attenuates 1-nitronaphthalene-induced cytotoxicity in nasal mucosa.

Authors:  Myong Gyong Lee; Asa M Wheelock; Bridget Boland; Charles G Plopper
Journal:  Am J Respir Cell Mol Biol       Date:  2007-09-27       Impact factor: 6.914

Review 10.  Mimicking the host and its microenvironment in vitro for studying mucosal infections by Pseudomonas aeruginosa.

Authors:  Aurélie Crabbé; Maria A Ledesma; Cheryl A Nickerson
Journal:  Pathog Dis       Date:  2014-05-23       Impact factor: 3.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.